Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of vatalanib (PTK787/ZK 222584) in metastatic cutaneous melanoma
2005-004710-33Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vatalanib in cutaneous melanoma (CM), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoints: time_to_progression and response_rate. Started May 2009; status: completed.
02
Drugs
vatalanib
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on 2005-004710-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004710-33.